Drug Profile


Alternative Names: B 80754; B 82733; B 8774; BY 744; BY 754

Latest Information Update: 24 Jun 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Developer ALTANA Pharma; MediGene AG; Nonindustrial source
  • Class Epoxy compounds; Small molecules
  • Mechanism of Action Carnitine O-palmitoyltransferase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Heart failure; Type 2 diabetes mellitus

Most Recent Events

  • 14 Jun 2002 Discontinued - Phase-II for Heart failure in Europe (PO)
  • 13 Jun 2002 A preclinical study has been added to the Heart Failure pharmacodynamics section
  • 22 Apr 2002 Suspended - Phase-II for Heart failure in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top